Home   Chapter Home   Jobs   Conferences   Fellowships   Books



Advertisement

Uterus (excludes Cervix)

Epithelial tumors

Mucinous Carcinoma


Reviewer: Mohamed Mokhtar Desouki, MD, PhD (see Reviewers page)
Revised: 22 August 2011, last major update August 2011
Copyright: (c) 2002-2011, PathologyOutlines.com, Inc.

General
=========================================================================

● Adenocarcinoma with abundant intracellular mucin
● May have enteric features
● May have a microglandular pattern with eosinophilic, mucinous intraluminal secretion and acute inflammation, simulating microglandular hyperplasia
● Mucin should be a predominant component of the tumor since scattered mucin is present in ordinary endometrial adenocarcinoma
● Mucinous carcinomas may be primed by exogenous estrogen therapy

Epidemiology
=========================================================================

● Rare tumor (<1% of endometrial carcinomas, up to 9% of stage I endometrial carcinomas) that affects patients 47-89 years

Etiology
=========================================================================

● Unknown

Clinical features
=========================================================================

● Most patients are menopausal and present with vaginal bleeding, usually not abdominal pain
● Both nulliparous and multiparous women

Prognostic factors
=========================================================================

● Usually FIGO grade 1 and nuclear grade 1 with favorable prognosis (Int J Gynecol Pathol 1987;6:347)

Treatment
=========================================================================

● Total abdominal hysterectomy with pre- and postoperative radiation

Gross description
=========================================================================

● Similar to other low-grade adenocarcinomas at gross examination; may not be grossly apparent
● Visible tumors vary from sessile polyps to nodules or irregular, thickened plaques that may be localized or diffuse

Micro description
=========================================================================

● Intracellular (not intraluminal) mucin is required for diagnosis; best demonstrated with mucicarmine or other mucin stain; however, mucin is easily visible with H&E staining
● Malignant features include architectural complexity of proliferation, epithelial stratification, loss of epithelial polarity, nuclear atypicality (Am J Surg Pathol 1983;7:715)
● Microglandular pattern and intestinal differentiation with goblet cells are different variants
● Low grade tumors also occur (Am J Surg Pathol 2011;35:537)

Micro images
=========================================================================



This invasive adenocarcinoma contains abundant mucin both within lumina and in the cytoplasm of the glandular cells


Irregular, confluent malignant glands are lined by well-differentiated cells containing intracytoplasmic mucin

Cytology description
=========================================================================

● Tumor cells arranged in papillary configuration and tumor cell clusters with bubbles in cytoplasm

Positive stains
=========================================================================

● Mucicarmine (mucin), vimentin, ER; also keratin; may be focally CEA+

Differential Diagnosis
=========================================================================

Primary, mucinous carcinoma of endocervix: CEA+, negative for vimentin and ER
Endocervical adenocarcinoma: may need differential biopsy and fractional curettage, not associated with endometrial hyperplasia or metaplasia, no foam cells
Mucinous metaplasia: no atypia
Microglandular hyperplasia: benign, no atypia

End of Uterus > Epithelial tumors > Mucinous carcinoma


This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must be interpreted in the context of a patient's clinical data using reasonable medical judgment. This website should not be used as a substitute for the advice of a licensed physician.

All information on this website is protected by copyright of PathologyOutlines.com, Inc. Information from third parties may also be protected by copyright. Please contact us at copyrightPathOut@gmail.com with any questions (click here for other contact information).